• Interaction Score: 0.86

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction MAP kinase p38 alpha inhibitor

  • Interaction Score: 0.46

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Ralimetinib + SCH772984
    Indication/Tumor Type pancreatic ductal adenocarcinoma
    Response Type sensitive

    PMIDs:
    26725216


    Sources:
    JAX-CKB